Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Invested Capital (2016 - 2025)

Historic Invested Capital for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $4.4 million.

  • Jaguar Health's Invested Capital fell 6671.76% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 6671.76%. This contributed to the annual value of $6.5 million for FY2024, which is 3261.18% up from last year.
  • Latest data reveals that Jaguar Health reported Invested Capital of $4.4 million as of Q3 2025, which was down 6671.76% from $6.9 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Invested Capital registered a high of $31.9 million during Q1 2021, and its lowest value of -$1.4 million during Q4 2022.
  • For the 5-year period, Jaguar Health's Invested Capital averaged around $10.0 million, with its median value being $6.9 million (2025).
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 195861.4% in 2021, then crashed by 11144.01% in 2022.
  • Over the past 5 years, Jaguar Health's Invested Capital (Quarter) stood at $11.9 million in 2021, then plummeted by 111.44% to -$1.4 million in 2022, then skyrocketed by 461.14% to $4.9 million in 2023, then skyrocketed by 32.61% to $6.5 million in 2024, then crashed by 32.88% to $4.4 million in 2025.
  • Its Invested Capital stands at $4.4 million for Q3 2025, versus $6.9 million for Q2 2025 and $830000.0 for Q1 2025.